Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical Trial

Aim: This study aimed to assess the potential effect of prior antithrombotic medication for thrombolysis in an unknown onset stroke. Methods: This was a predefined sub-analysis of the THAWS trial. Stroke patients with a time last known well ＞4.5 h who had a DWI-fluid-attenuated inversion recovery mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Koga, Masatoshi, Inoue, Manabu, Miwa, Kaori, Yoshimura, Sohei, Fukuda-Doi, Mayumi, Aoki, Junya, Asakura, Koko, Kanzawa, Takao, Ohtaki, Masafumi, Kamiyama, Kenji, Yakushiji, Yusuke, Igarashi, Shuichi, Doijiri, Ryosuke, Ito, Yasuhiro, Takagi, Yasushi, Sasaki, Makoto, Kitazono, Takanari, Kimura, Kazumi, Minematsu, Kazuo, Yamamoto, Haruko, Toyoda, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899700/
https://www.ncbi.nlm.nih.gov/pubmed/35197420
http://dx.doi.org/10.5551/jat.63337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899700/
https://www.ncbi.nlm.nih.gov/pubmed/35197420
http://dx.doi.org/10.5551/jat.63337

Ejemplares similares